Health October 26 Popular weight-loss drugs could take the edge off your alcohol buzz, study finds GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying gastric emptying, researchers report.
Soft Drinks October 18 Scientists reveal how your favorite soda could quietly mess with your mood Women who regularly consume soft drinks face a 16% higher risk of major depression, according to new research examining gut bacteria and mental health connections.
Food-Drink October 16 Even low-calorie processed food causes weight gain, testosterone loss in men, study suggests Danish researchers suggest that food processing itself harms men's metabolic and reproductive health, prompting calls to revise nutritional guidelines.
Health October 10 Ozempic and similar drugs could interfere with common medical procedure, research warns A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more data is needed before changing medical practice.
Health October 7 Experts sound alarm as weight-loss shortcut could put Americans at risk High costs and shortages are driving demand for unregulated GLP-1 drugs, prompting FDA alerts about counterfeit Ozempic and calls for stricter enforcement by legal experts.
Health October 2 Weight-loss surgery pros and cons in the spotlight after singer's 'scary' experience Weight-loss experts explain why combining GLP-1 medications with bariatric surgery may be the most effective approach to treating obesity in 2025.
Health September 29 Weight-loss drugs now linked to cancer protection in women, major new study reveals A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults. Oncologist Dr. Slomovitz discusses the findings.
VIDEO September 28 Oncology director shares how GLP-1s can help protect against cancer Dr. Brian Slomovitz, director of gynecologic oncology at Mount Sinai Medical Center in Miami Beach, Florida, says the link between GLP-1 and reduced cancer risk is "not surprising."
Health September 25 Weight-loss doctor shares how GLP-1s could rewire body against disease New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.
VIDEO September 24 Weight loss drugs show promise in reducing inflammation beyond fat burning, doctor says Dr. Sue Decotiis, a New York City weight loss physician, discusses how GLP-1s impact inflammation, relieving conditions from arthritis to cancer.
Health September 23 No more injections? New pill could replace Ozempic and Wegovy for weight loss A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially providing an easier alternative to Ozempic injections.